Hydroxyzine Pamoate Capsule
Product Images NDC 55154-2337

3 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hydroxyzine Pamoate (NDC 55154-2337). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Bdb22fcc B768 493e A8e0 09975b3aba6a 01)

Structure (Bdb22fcc B768 493e A8e0 09975b3aba6a 01)
Chemical structure depicting hydroxyzine pamoate, showing the molecular configuration of the active ingredient in this prescription drug product.*
FDA Label Image

Image (Bdb22fcc B768 493e A8e0 09975b3aba6a 02)

FDA Label Image

25mg Bag Label (52c2f407 7a34 4a45 88ab D4db6e4dd4c1 00)

25mg Bag Label (52c2f407 7a34 4a45 88ab D4db6e4dd4c1 00)
Drug Facts label for hydroxyzine pamoate capsules, USP 25 mg, in a 10-capsule unit dose package. The label includes dosage information, storage instructions, warnings, packaging and distribution details, and notes that the product is tartrazine dye free and intended for institutional use only. Distributor is Cardinal Health, Dublin, OH.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.